Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,100,880
-
Share change
-
+14,100,880
-
Total reported value
-
$214,196,000
-
Price per share
-
$15.19
-
Number of holders
-
58
-
Value change
-
+$214,196,001
-
Number of buys
-
58
Institutional Holders of RA PHARMACEUTICALS INC - COM (RARX) as of Q4 2016
As of 31 Dec 2016,
RA PHARMACEUTICALS INC - COM (RARX) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,100,880 shares.
The largest 10 holders included
NEA Management Company, LLC, Novo A/S, WELLINGTON MANAGEMENT GROUP LLP, RA CAPITAL MANAGEMENT, LLC, Rock Springs Capital Management LP, VHCP Management II, LLC, ACUTA CAPITAL PARTNERS, LLC, FRANKLIN RESOURCES INC, DEERFIELD MANAGEMENT CO, and Sectoral Asset Management Inc.
This page lists
58
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.